DS-7250 -Evaluation of Safety, Pharmacokinetics, and Pharmacodynamics After Multiple Oral Administration in Patients With Type 2 Diabetes
Phase 1
- Conditions
- Type 2 Diabetes Mellitus
- Registration Number
- JPRN-jRCT2080221918
- Lead Sponsor
- DAIICHISANKYO Co.,Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
The patients who are diagonosed with type 2 diabetes mellitus
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method